Artrya Limited (ASX:AYA)
Australia · Delayed Price · Currency is AUD 3.450
+0.100 (2.99%)
Dec 4, 2025, 3:55 PM AEST
Artrya Market Cap
Artrya has a market cap or net worth of 529.58 million as of December 3, 2025. Its market cap has increased by 1,300.94% in one year.
Market Cap
529.58M
Enterprise Value
518.87M
Revenue
28.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
3.45
Market Cap Chart
Since November 26, 2021, Artrya's market cap has increased from 119.12M to 529.58M, an increase of 344.57%. That is a compound annual growth rate of 44.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 529.58M | 992.28% |
| Dec 31, 2024 | 48.48M | 156.86% |
| Dec 29, 2023 | 18.88M | -39.81% |
| Dec 30, 2022 | 31.36M | -69.23% |
| Dec 31, 2021 | 101.94M | -14.43% |
| Nov 26, 2021 | 119.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 88.56B |
| Pro Medicus | 27.16B |
| Cochlear | 17.94B |
| Sonic Healthcare | 11.43B |
| Ramsay Health Care | 8.64B |
| Ansell | 5.20B |
| Telix Pharmaceuticals | 4.89B |
| Mesoblast | 3.23B |